162 related articles for article (PubMed ID: 33413879)
21. Exacerbation of Intimal Fibrosis and Endarteritis in a Kidney Transplant Recipient with Chronic Active Antibody-Mediated Rejection and COVID-19: A Case Report.
Otsuka T; Tanabe T; Hotta K; Iwasaki S; Tsuji T; Takahashi A; Takakuwa E; Shinohara N; Matsuno Y
Nephron; 2023; 147 Suppl 1():41-45. PubMed ID: 37276843
[TBL] [Abstract][Full Text] [Related]
22. Management of sensitized pediatric patients prior to renal transplantation.
Pirojsakul K; Desai D; Lacelle C; Seikaly MG
Pediatr Nephrol; 2016 Oct; 31(10):1691-8. PubMed ID: 26801944
[TBL] [Abstract][Full Text] [Related]
23. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
[TBL] [Abstract][Full Text] [Related]
24. Development of antibody mediated rejection shortly after acute cellular rejection in a pediatric kidney transplantation recipient.
Okada M; Kamei K; Matsuoka K; Ito S
CEN Case Rep; 2018 Nov; 7(2):288-291. PubMed ID: 29949115
[TBL] [Abstract][Full Text] [Related]
25. Antibody-mediated rejection due to anti-HLA-DQ antibody after pregnancy and delivery in a female kidney transplant recipient.
Sagasaki M; Nakada Y; Yamamoto I; Kawabe M; Yamakawa T; Katsumata H; Mafune A; Katsuma A; Kobayashi A; Koike K; Koike Y; Miki J; Yamada H; Kimura T; Tanno Y; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():81-84. PubMed ID: 29968405
[TBL] [Abstract][Full Text] [Related]
26. Using Both Plasma and Urine Donor-Derived Cell-Free DNA to Identify Various Renal Allograft Injuries.
Chen XT; Qiu J; Wu ZX; Zhang H; Chen T; Yang SC; Zhao GD; He Y; Shen X; Luo JQ; Huang Y; Wang CX; Chen LZ; Wu CL; Huang G
Clin Chem; 2022 Jun; 68(6):814-825. PubMed ID: 35587713
[TBL] [Abstract][Full Text] [Related]
27. Intensive plasmapheresis and intravenous immunoglobulin for treatment of antibody-mediated rejection after kidney transplant.
Ruangkanchanasetr P; Satirapoj B; Termmathurapoj S; Namkhanisorn K; Suaywan K; Nimkietkajorn V; Luesutthiviboon L
Exp Clin Transplant; 2014 Aug; 12(4):328-33. PubMed ID: 25095710
[TBL] [Abstract][Full Text] [Related]
28. Use of high-dose human immune globulin in highly sensitized patients on the kidney transplant waiting list: one center's experience.
Gozdowska J; Urbanowicz A; Perkowska-Ptasinska A; Michalska K; Chmura A; Szmidt J; Durlik M
Transplant Proc; 2009 Oct; 41(8):2997-3001. PubMed ID: 19857660
[TBL] [Abstract][Full Text] [Related]
29. Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response.
Serrano OK; Kutzler HL; Rochon C; Radojevic JA; Lawlor MT; Hammond JA; Gluck J; Feingold AD; Jaiswal A
Transpl Infect Dis; 2020 Dec; 22(6):e13367. PubMed ID: 32533615
[TBL] [Abstract][Full Text] [Related]
30. Liquid biopsies: donor-derived cell-free DNA for the detection of kidney allograft injury.
Oellerich M; Sherwood K; Keown P; Schütz E; Beck J; Stegbauer J; Rump LC; Walson PD
Nat Rev Nephrol; 2021 Sep; 17(9):591-603. PubMed ID: 34031575
[TBL] [Abstract][Full Text] [Related]
31. Ig-responsive relapsing inflammatory syndrome following COVID-19 in a kidney transplant recipient.
Chavarot N; Burger C; Aguilar C; Scemla A; Sberro-Soussan R; Amrouche L; Leruez-Ville M; Martinez F; Legendre C; Anglicheau D; Zuber J
Kidney Int; 2021 Mar; 99(3):767-768. PubMed ID: 33518372
[No Abstract] [Full Text] [Related]
32. The transmission of donor-derived malignant melanoma to a renal allograft recipient.
Milton CA; Barbara J; Cooper J; Rao M; Russell C; Russ G
Clin Transplant; 2006; 20(5):547-50. PubMed ID: 16968479
[TBL] [Abstract][Full Text] [Related]
33. Protocol-based donor-derived cell-free DNA surveillance in kidney transplant recipients: A single-center experience.
Nissaisorakarn P; Patel H; Amtul A; Pavlakis M
Clin Nephrol; 2022 Aug; 98(2):65-74. PubMed ID: 35445660
[TBL] [Abstract][Full Text] [Related]
34. Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy?
Franz M; Regele H; Schmaldienst S; Stummvoll HK; Hörl WH; Pohanka E
Transplantation; 1998 Nov; 66(9):1258-62. PubMed ID: 9825827
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
36. An Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function.
Huang E; Haas M; Gillespie M; Sethi S; Peng A; Najjar R; Vo A; Jordan SC
Transplantation; 2023 Jan; 107(1):274-282. PubMed ID: 35913057
[TBL] [Abstract][Full Text] [Related]
37. Kidney paired donation in the presence of donor-specific antibodies.
Blumberg JM; Gritsch HA; Reed EF; Cecka JM; Lipshutz GS; Danovitch GM; McGuire S; Gjertson DW; Veale JL
Kidney Int; 2013 Nov; 84(5):1009-16. PubMed ID: 23715120
[TBL] [Abstract][Full Text] [Related]
38. Highly Sensitized Patients: Miami Transplant Institute Experience.
Mattiazzi AD; Centeno A; Amador A; Fernandez-Bango C; Scowby CD; O'Rourke M; Hill-Matthie T; Patel R; Barrios F; Ruiz P; Chen L; Saghesima J; Ciancio G; Burke GW; Goldstein M; Chandar J; Contreras G; Roth D; Kupin W; Guerra G; Vianna R
Clin Transpl; 2014; ():171-8. PubMed ID: 26281142
[TBL] [Abstract][Full Text] [Related]
39. Case Report: Successful Response to Intravenous Immunoglobulin and Steroid Pulses in a Renal Transplant Recipient With Severe Covid-19 Disease and Associated Acute Allograft Failure.
Rosa-Guerrero P; Trujillo-Aguilera A; Molina J; Navas A; López-Martín C; Jurado A; Rodríguez-Benot A; Torres-De-Rueda Á
Front Immunol; 2021; 12():671013. PubMed ID: 34046038
[TBL] [Abstract][Full Text] [Related]
40. Impact of Donor Specific HLA Antibody Monitoring After Kidney Transplantation.
Rao S; Ghanta M; Lee IJ; Gillespie A; Parekh HK; Geier SS; Zeng X; Karachristos A; Lau KN; Karhadkar S; Di Carlo A; Sifontis NM; Constantinescu S
Clin Transpl; 2014; ():143-51. PubMed ID: 26281139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
